Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional study

被引：0
|
作者：
Yu, C. C. [1 ]
Wang, Y. F. [1 ,2 ,3 ]
Kuan, A. S. [2 ,3 ,4 ]
Chen, S. P. [1 ,3 ,4 ,5 ]
Wang, J. [1 ,3 ,4 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Neurosurg, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan
[4] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
AL015
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [31] Monitoring chronic headache and medication-overuse headache prevalence in Denmark
    Westergaard, Maria Lurenda
    Lau, Cathrine Juel
    Allesoe, Karen
    Gjendal, Signe Thorup
    Jensen, Rigmor Hojland
    CEPHALALGIA, 2020, 40 (01) : 6 - 18
  • [32] Medication-overuse headache detoxification reduces headache disability - the Akershus study of chronic headache
    Kristoffersen, E. S.
    Grande, R. B.
    Aaseth, K.
    Russell, M. B.
    Lundqvist, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (09) : 1140 - 1147
  • [33] The use of MIDAS in patients with chronic migraine and medication-overuse headache: should we trust it?
    Raggi, Alberto
    Grazzi, Licia
    Grignani, Eleonora
    Leonardi, Matilde
    Sansone, Emanuela
    Scaratti, Chiara
    D'Amico, Domenico
    NEUROLOGICAL SCIENCES, 2018, 39 : S125 - S127
  • [34] The use of MIDAS in patients with chronic migraine and medication-overuse headache: should we trust it?
    Alberto Raggi
    Licia Grazzi
    Eleonora Grignani
    Matilde Leonardi
    Emanuela Sansone
    Chiara Scaratti
    Domenico D’Amico
    Neurological Sciences, 2018, 39 : 125 - 127
  • [35] Treatment with eptinezumab for migraine prevention in people with chronic migraine and medication-overuse headache: A Plain Language Summary
    Starling, Amaal J.
    Kolbet, Melissa
    Cady, Roger
    Brevig, Thomas
    PAIN MANAGEMENT, 2023, 13 (06) : 317 - 327
  • [36] Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache
    Marmura, Michael J.
    Diener, Hans-Christoph
    Cowan, Robert P.
    Tepper, Stewart J.
    Diamond, Merle L.
    Starling, Amaal J.
    Hirman, Joe
    Mehta, Lahar
    Brevig, Thomas
    Cady, Roger
    HEADACHE, 2021, 61 (09): : 1421 - 1431
  • [37] PERSONALITY PROFILES OF MIGRAINE HEADACHE PATIENTS AS COMPARED TO MEDICATION-OVERUSE HEADACHE PATIENTS
    Mose, L. S.
    Pedersen, S. S.
    Jensen, R. H.
    Gram, B.
    CEPHALALGIA, 2016, 36 : 129 - 130
  • [38] Medication-overuse headache: A pharmacovigilance study in France
    Al Balkhi, Mohamad Houssam
    Moragny, Julien
    Laville, Solene M.
    Liabeuf, Sophie
    Pecquet, Pauline-Eva
    Batteux, Benjamin
    Le Souder, Cosette
    Bellet, Florelle
    Gras, Valerie
    Masmoudi, Kamel
    THERAPIE, 2024, 79 (05): : 565 - 575
  • [39] Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels
    Cristiana Rossi
    Luigi Alberto Pini
    Maria Letizia Cupini
    Paolo Calabresi
    Paola Sarchielli
    European Journal of Clinical Pharmacology, 2008, 64 : 1 - 8
  • [40] Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels
    Rossi, Cristiana
    Pini, Luigi Alberto
    Cupini, Maria Letizia
    Calabresi, Paolo
    Sarchielli, Paola
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (01) : 1 - 8
12345